HLA
ABMD

Hamilton Lane Advisors’s Abiomed Inc ABMD Stock Holding History

Hamilton Lane Advisors’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-3,089
Closed -$1K – 56
2018
Q2 		$1K Sell
3,089
-596
-16% -$216K 0.91% 32
2018
Q1 		$1K Sell
3,685
-19,556
-84% -$4.96M 0.79% 31
2017
Q4 		$4.36M Buy
23,241
+7,827
+51% +$1.46M 2.25% 13
2017
Q3 		$2.6M Buy
+15,414
New +$2.33M 1.78% 13
2015
Q3 		– Sell
-70,392
Closed -$4.63M – 61
2015
Q2 		$4.63M Buy
+70,392
New +$4.68M 1.75% 19

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Hamilton Lane Advisors's ABMD Position: Q3 2018 in Review

Hamilton Lane Advisors sold out of Abiomed Inc (ABMD) in Q3 2018, closing a stake of 3,089 shares — an estimated $1K sold.

Hamilton Lane Advisors first reported a position in ABMD in Q2 2015 and held it in 5 quarters. The position peaked at $4.63M in Q2 2015. 529 funds tracked by Wall St. Rank hold ABMD as of Q3 2018.

  • Hamilton Lane Advisors reported no remaining Abiomed Inc position as of Q3 2018 after selling out during the quarter.
  • Hamilton Lane Advisors sold 3,089 Abiomed Inc shares in Q3 2018, an estimated $1K.
  • Hamilton Lane Advisors first reported a position in Abiomed Inc in Q2 2015 and held it in 5 quarters.
  • Hamilton Lane Advisors's Abiomed Inc position peaked at $4.63M in Q2 2015.
  • 529 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2018.

Based on Hamilton Lane Advisors's 13F filing for Q3 2018, filed 16 Oct 2018.